title: New developments in biological markers of bone metabolism in osteoporosis.
abstract: Over the last 15 years several biological markers of bone turnover have been developed with increased specificity and sensitivity. In osteoporosis clinical studies, the IOF and IFCC organizations have recently recommended the measurements of serum type I collagen N-propeptide (PINP) and the crosslinked C-terminal telopeptide (serum CTX) as markers of bone formation and bone resorption, respectively. However these markers have some limitations including a lack of specificity for bone tissue, their inability to reflect osteocyte activity or periosteal apposition. In addition they do not allow the investigation of bone tissue quality an important determinant of skeletal fragility. To address these limitations, new developments in markers of bone metabolism have been recently achieved. These include assays for periostin, a matricellular protein preferentially localized in the periosteal tissue, sphingosine 1-phosphate, a lipid mediator which acts mainly on osteoclastogenesis and the osteocyte factors such as sclerostin and FGF-23. Recent studies have shown an association between the circulating levels of these biological markers and fracture risk in postmenopausal women or elderly men, although data require confirmation in additional prospective studies. Finally, recent studies suggest that the measurements of circulating microRNAs may represent a novel class of early biological markers in osteoporosis. It is foreseen that with the use of genomics and proteomics, new markers will be developed to ultimately improve the management of patients with osteoporosis.
authors.affiliation: INSERM Research Unit 1033, University of Lyon, France and Cisbio Bioassays, Codolet, France. Electronic address: patrickgarnero@free.fr.
authors.forename: Patrick
authors.initials: P
authors.lastname: Garnero
mesh_terms: D015415:Biomarkers / Q000097:blood / Q000378:metabolism*; D001842:Bone and Bones / Q000378:metabolism*; D000089703:Fibroblast Growth Factor-23; D006801:Humans; D008954:Models, Biological; D010024:Osteoporosis / Q000097:blood / Q000378:metabolism*
chemical_list: D015415:Biomarkers; C000717427:FGF23 protein, human; D000089703:Fibroblast Growth Factor-23
keywords: Bone markers; FGF-23; Osteoporosis; Periostin; Sclerostin; microRNA